4//SEC Filing
Janssen Robert 4
Accession 0001209191-24-003286
CIK 0001029142other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 8:46 PM ET
Size
9.2 KB
Accession
0001209191-24-003286
Insider Transaction Report
Form 4
Janssen Robert
Chief Medical Officer and VP
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-02-10−4,333→ 4,333 total→ Common Stock (4,333 underlying) - Exercise/Conversion
Common Stock
2024-02-10+4,333→ 60,215 total - Tax Payment
Common Stock
2024-02-12$12.82/sh−1,531$19,627→ 58,684 total
Footnotes (4)
- [F1]Code M: Exercise or conversion of derivative security
- [F2]Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022.
- [F3]Code F: Payment of exercise price or tax liability by delivering or withholding securities
- [F4]Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.
Documents
Issuer
DYNAVAX TECHNOLOGIES CORP
CIK 0001029142
Entity typeother
Related Parties
1- filerCIK 0001580849
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 8:46 PM ET
- Size
- 9.2 KB